Benjamin Suttle

1.0k citations
21 papers · 763 · 1 hit paper · h-index 9

Impact in

Papers in

    • Melanoma and MAPK Pathways 3
    • Renal and related cancers 2
    • Colorectal Cancer Treatments and Studies 5
    • Cancer Treatment and Pharmacology 4

Benjamin Suttle

20 papers receiving 754 citations

Benjamin Suttle's Hit Papers

Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study 2018 · 462 citations
4620+2+5Years since publication100200300400

Peers

Benjamin Suttle
Comparison fields: 5 of 55
  • Pathology and Forensic Medicine 152
  • Oncology 224
  • Cancer Research 108
  • Molecular Biology 485
  • Genetics 66
Replace Daniela Graziani with:
Daniela Graziani Italy
H. J. Illiger Germany
Deborah Ricci United States
Sharon Friedlander United States
W. Li China
P.N. Munster United States
Bethany Pitcher Canada
Christoph Heining Germany
Christopher Riley United States
J.P. Delord France
Benjamin Suttle relative to Daniela Graziani Italy Daniela Graziani's profile →
Citations per field
00.5×10×13.2×
Daniela Graziani · 1×
Citations per year

Countries citing papers authored by Benjamin Suttle

Since Specialization
Citations

This map shows the geographic impact of Benjamin Suttle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Suttle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Suttle more than expected).

Fields of papers citing papers by Benjamin Suttle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Suttle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Suttle. The network helps show where Benjamin Suttle may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Suttle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Suttle Line = papers co-authored together Benjamin Suttle links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Hit paper breakdown →
2018462
2 200564
3 202055
4 201445
5 201023
6 201422
7 201519
8 201116
9 199514
10 20087
11 20126
12 20076
13 20116
14 20145
15 20144
16
A STUDY OF THE EFFECTS OF INHIBITION OF CYP3A4 BY KETOCONAZOLE (K) AND CYP2C8 BY GEMFIBROZIL (G) ON THE PHARMACOKINETICS DABRAFENIB (D)
20143
17 20182
18 20162
19 20031
20
A Multi-Targeted Receptor Tyrosine Kinase Inhibitor for the Treatment of Neovascular AMD: Results of a Healthy Volunteer Safety and Tolerability Study of Pazopanib Eye Drops
20091

About Benjamin Suttle

Benjamin Suttle is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 21 papers that have together received 763 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Genomics and Diagnostics (4 papers), Renal cell carcinoma treatment (4 papers), Cancer Treatment and Pharmacology (4 papers), Melanoma and MAPK Pathways (3 papers), Lung Cancer Treatments and Mutations (3 papers), Renal and related cancers (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (152 citations), Oncology (224 citations), Cancer Research (108 citations), Molecular Biology (485 citations) and Genetics (66 citations). Benjamin Suttle has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Peter Ho, Jean‐Marie Michot, Vincent Ribrag, Alice McDonald, Jean‐Michel Coindre, Mark Woodruff, Jean‐Charles Soria, Antoîne Italiano, Carlo Lucchesi and Maud Toulmonde. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, European Journal of Cancer and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact